Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
574
-
Total 13F shares, excl. options
-
68.6M
-
Shares change
-
+804K
-
Total reported value, excl. options
-
$19.4B
-
Value change
-
+$199M
-
Put/Call ratio
-
1.21
-
Number of buys
-
285
-
Number of sells
-
-251
-
Price
-
$283.31
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2020
652 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q4 2020.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 574 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.6M shares
of 71.9M outstanding shares and own 95.38% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.29M shares), BlackRock Inc. (7.29M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.62M shares), FRANKLIN RESOURCES INC (3.85M shares), STATE STREET CORP (3.35M shares), Invesco Ltd. (1.73M shares), Neuberger Berman Group LLC (1.64M shares), WCM INVESTMENT MANAGEMENT, LLC (1.61M shares), BAMCO INC /NY/ (1.34M shares), and Artisan Partners Limited Partnership (1.3M shares).
This table shows the top 574 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.